FEATURED ARTICLES
2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets
Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.
-
![business team lifting blocks-GettyImages-1322009979]( "Never Underestimate The Power Of Clinical Operations")
Never Underestimate The Power Of Clinical OperationsToo often, clinical operations is treated as a transactional or downstream function, says clinical operations strategist Suzanne Vyvoda. She wants to change how we see and treat ClinOps.
-
![women receiving ophthalmology treatment-GettyImages-2194514292]( "Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients")
Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease PatientsOcugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.
-
![AI artificial intelligence chatbot-GettyImages-1598676527]( "What's The Risk Of Letting Researchers Use LLMs?")
What's The Risk Of Letting Researchers Use LLMs?Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.
SERVICES & PRODUCTS
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC Services
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
Experience customized and validated flow cytometry (FCM) biomarkers and panels for your clinical research on a global scale. Learn how FCM can enhance your research and help develop the panels you need.
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.